- Home
- ITRM vs HIND Comparison
ITRM vs HIND Comparison
Compare ITRM & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITRM | HIND |
|---|---|---|
| Founded | 2015 | N/A |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 28.0M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ITRM | HIND |
|---|---|---|
| Price | $0.34 | $3.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 968.4K | N/A |
| Earning Date | 03-20-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $390,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $193.01 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.26 | N/A |
| 52 Week High | $1.75 | N/A |
Technical Indicators
Market Signals| Indicator | ITRM | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 45.51 | 42.62 |
| Support Level | $0.31 | $3.00 |
| Resistance Level | $0.39 | $3.25 |
| Average True Range (ATR) | 0.03 | 0.27 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 33.84 | 51.49 |
Price Performance
Historical ComparisonAbout ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About HIND Vyome Holdings Inc.
Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.